Cargando…

Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016

Objective: No assessment was conducted describing the age and gender specific epidemiology of lung cancer (LC) prior to 2018 in Hungary, thus the objective of this study was to appraise the detailed epidemiology of lung cancer (ICD-10 C34) in Hungary based on a retrospective analysis of the National...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamási, Lilla, Horváth, Krisztián, Kiss, Zoltán, Bogos, Krisztina, Ostoros, Gyula, Müller, Veronika, Urbán, László, Bittner, Nóra, Sárosi, Veronika, Vastag, Aladár, Polányi, Zoltán, Nagy-Erdei, Zsófia, Daniel, Andrea, Nagy, Balázs, Rokszin, György, Abonyi-Tóth, Zsolt, Moldvay, Judit, Vokó, Zoltán, Gálffy, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Society Journal Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262188/ https://www.ncbi.nlm.nih.gov/pubmed/34257553 http://dx.doi.org/10.3389/pore.2021.598862

Ejemplares similares

Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary
por: Kiss, Zoltan, et al.
Publicado: (2021)

Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary
por: Bogos, Krisztina, et al.
Publicado: (2019)

Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016
por: Gálffy, Gabriella, et al.
Publicado: (2021)

Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011–2016
por: Bogos, Krisztina, et al.
Publicado: (2021)

Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study)
por: Kiss, Zolta´n, et al.
Publicado: (2022)

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
por: Kiss, Zoltán, et al.
Publicado: (2023)

Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis
por: Bogos, Krisztina, et al.
Publicado: (2021)

Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study
por: Liszkay, Gabriella, et al.
Publicado: (2021)

Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)
por: Vokó, Zoltán, et al.
Publicado: (2022)

Persistence with statin therapy in Hungary
por: Kiss, Zoltan, et al.
Publicado: (2013)

Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)
por: Kiss, Zoltán, et al.
Publicado: (2022)

EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of Results in a Three-Year Period and a Comparison of Commercially Available Detection Kits
por: Bencze, Eszter, et al.
Publicado: (2022)

Improving Quality Indicator of Melanoma Management – Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study
por: Várnai, Máté, et al.
Publicado: (2021)

A survey of the burden of allergic rhinitis in Hungary from a specialist’s perspective
por: Szilasi, Mária, et al.
Publicado: (2012)

Lung cancer drug therapy in Hungary – 3-year experience
por: Moldvay, Judit, et al.
Publicado: (2015)

Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary
por: Müller, Judit, et al.
Publicado: (2022)

General practitioners can increase participation in cervical cancer screening – a model program in Hungary
por: Gyulai, Anikó, et al.
Publicado: (2018)

Different Changes of Risks for Stroke and Myocardial Infarction in Patients With Type 2 Diabetes in Hungary Between the Two Periods of 2001–2004 and 2010–2013
por: Kiss, Zoltan, et al.
Publicado: (2019)

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020
por: Kiss, Zoltán, et al.
Publicado: (2023)

Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary
por: Kiss, Zoltán, et al.
Publicado: (2018)

Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
por: Vokó, Zoltán, et al.
Publicado: (2012)

Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020—Nationwide Data from a Register-Based Analysis
por: Jermendy, György, et al.
Publicado: (2022)

Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016 – a nationwide population-based study
por: Barkai, László, et al.
Publicado: (2019)

Pitfalls associated with the therapeutic reference pricing practice of asthma medication
por: Kalo, Zoltan, et al.
Publicado: (2012)

Inhaler Competence and Patient Satisfaction with Easyhaler(®): Results of Two Real-Life Multicentre Studies in Asthma and COPD
por: Gálffy, Gabriella, et al.
Publicado: (2013)

PD-1 and PD-L1 expression in rare lung tumors
por: Gyulai, Marton, et al.
Publicado: (2023)

Inequalities in Diabetes Mortality Between Microregions in Hungary
por: Kollányi, Zsófia, et al.
Publicado: (2023)

Substantial variation across geographic regions in the obesity prevalence among 6–8 years old Hungarian children (COSI Hungary 2016)
por: Erdei, Gergő, et al.
Publicado: (2018)

Circulating Survivin Protein Levels in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
por: Puskas, Rita, et al.
Publicado: (2021)

From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)
por: Lohinai, Zoltan, et al.
Publicado: (2016)

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial
por: Markóczy, Zsolt, et al.
Publicado: (2018)

Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile
por: Ratku, Balázs, et al.
Publicado: (2022)

Incremental cost of premature birth – a public health care payer perspective from Hungary
por: Kovács, Gábor, et al.
Publicado: (2023)

Consumer acceptance of genetic-based personalized nutrition in Hungary
por: Szakály, Zoltán, et al.
Publicado: (2021)

Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study
por: Vokó, Zoltán, et al.
Publicado: (2022)

Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor
por: Radeczky, Peter, et al.
Publicado: (2021)

Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases
por: Gál, Zsófia, et al.
Publicado: (2020)

Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant
por: Müller, Veronika, et al.
Publicado: (2022)

Human cases of lymphocytic choriomeningitis virus (LCMV) infections in Hungary
por: Pankovics, Péter, et al.
Publicado: (2023)

The characteristics of head and neck squamous cell cancer in young adults: A retrospective single-center study
por: Révész, Mónika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_693lohim0ovithjklmk3amhi8j